XML 48 R113.htm IDEA: XBRL DOCUMENT v3.20.1
Note 17 - Shareholders' Equity - Disclosure of Share-based Compensation Arrangements by Share-based Payment Award (Details) - € / shares
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Non-vested options granted (in shares) 155,000    
Share-based Payment Arrangement, Option [Member]      
Outstanding - number (in shares) 1,347,600 1,207,600 1,427,438
Outstanding - Weighted average exercise price (in EUR per share) € 2.61 € 2.61 € 2.94
Non-vested options granted (in shares) 155,000 165,000 260,000
Granted - Weighted average exercise price (in EUR per share) € 3.90 € 2.65 € 2.39
Exercised - number (in shares) (143,700) (60,000)
Exercised - Weighted average exercise price (in EUR per share) € 2.16 € 1.91
Forfeited - number (in shares) (85,000) (25,000) (134,750)
Forfeited - Weighted average exercise price (in EUR per share) € 1.94 € 3.05 € 3.09
Expired - number (in shares) (285,088)
Expired - Weighted average exercise price (in EUR per share) € 3.99
Outstanding - number (in shares) 1,273,900 1,347,600 1,207,600
Outstanding - Weighted average exercise price (in EUR per share) € 2.78 € 2.61 € 2.61
Exercisable - number (in shares) 818,900 772,600 598,850
Exercisable - Weighted average exercise price (in EUR per share) € 2.60 € 2.44 € 2.29
Share purchase options available for grant - number (in shares) 250,428 250,428 250,428